This novel therapeutic approach utilizes specialized lipid nanoparticles (LNPs) to deliver follistatin messenger RNA (mRNA) directly to lung tumors, simultaneously inhibiting cancer growth and reversing cachexia, a severe muscle-wasting syndrome.
#Oncology #Pharmacology #Nanomedicine #MolecularGenetics #cancer #sflorg
https://www.sflorg.com/2026/04/ongy04062601.html
Researchers find way to treat lung cancer and associated muscle wasting at the same time

Lung cancer is the leading cause of cancer death in the United States, and cachexia is responsible for up to 30% of those fatalities